Mengjuan Wei
- Molecular Biology
- Pharmacology top 5%
- Epidemiology
- Pharmacology
- Hepatology top 10%
- Topics
- Liver Disease Diagnosis and Treatment (11 papers)Drug-Induced Hepatotoxicity and Protection (8 papers)Genomics, phytochemicals, and oxidative stress (4 papers)
- Partner nations
- China
In The Last Decade
Mengjuan Wei
24 papers receiving 519 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 227
- Pharmacology 147
- Epidemiology 146
- Pharmacology 72
- Hepatology 70
Countries citing papers authored by Mengjuan Wei
This map shows the geographic impact of Mengjuan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengjuan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengjuan Wei more than expected).
Fields of papers citing papers by Mengjuan Wei
This network shows the impact of papers produced by Mengjuan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengjuan Wei. The network helps show where Mengjuan Wei may publish in the future.
Co-authorship network of co-authors of Mengjuan Wei
This figure shows the co-authorship network connecting the top 25 collaborators of Mengjuan Wei. A scholar is included among the top collaborators of Mengjuan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengjuan Wei. Mengjuan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 17 | |
| 8 | 2 | |
| 9 | 34 | |
| 10 | 11 | |
| 11 | 6 | |
| 12 | 15 | |
| 13 | 8 | |
| 14 | 38 | |
| 15 | 14 | |
| 16 | 37 | |
| 17 | 63 | |
| 18 | 26 | |
| 19 | 120 | |
| 20 | 18 |
About Mengjuan Wei
Mengjuan Wei is a scholar working on Pharmacology, Hepatology and Epidemiology, having authored 25 papers that have together received 522 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). The work is most often cited by research in Pharmacology (147 citations), Hepatology (70 citations) and Complementary and alternative medicine (38 citations). Mengjuan Wei has collaborated with scholars based in China. Frequent co-authors include Lili Ji, Liang Shi, Bin Lü, Shaobo Zhang, Zhenlin Huang, Zhengtao Wang, Zhiyong Zheng, Jin Yao, Feifei Hu and Yuchen Sheng. Their work appears in journals such as Free Radical Biology and Medicine, Biochemical Pharmacology and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.